Explore 3 Stock Ideas & Industry Insights Download Free Report

BioHarvest Sciences Inc. Common Stock

Company price
1.23 USD 0.01 ( 0.82%)
Last update at 2026-11-18T21:00:00Z
VOLUME
6060
Market Cap
100.19M

Momentum Score

…

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and sale of science-based health and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
1.16
Low
1.27
High
52 Week Price Range
4.10
Low
12.80
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
1.22
Dividend Yield
-
Revenue TTM
34.51M
Revenue Per Share
1.87
Gross Profit TTM
20.48M
Debt / Equity
-
ROE
-83.17%
Net Debt
1.51M
ROCE
-13.94%
Diluted EPS TTM
-0.60

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -11.06M -12.90M -12.56M -11.24M -9.83M
Net income -11.13M -12.91M -12.56M -11.24M -9.83M
Selling general administrative 19.14M 14.67M 12.08M 9.35M 4.76M
Gross profit 20.48M 13.94M 5.63M 1.22M 0.67M
Reconciled depreciation 1.62M 1.25M 0.84M 0.71M 0.39M
Ebit - -6.99M -9.97M -10.61M -8.49M
Operating income -5.58M -6.99M -9.97M -10.61M -8.49M
Interest expense 2.72M 4.74M 1.96M 1.40M 0.81M
Tax provision 0.08M 0.01M 0.00M - -
Interest income 0.05M 0.00M - - 0.00M
Net interest income -3.65M -5.43M -2.10M -1.49M -0.85M
Total revenue 34.51M 25.19M 12.67M 5.50M 2.10M
Total operating expenses 40.08M 32.18M 22.64M 16.11M 10.59M
Cost of revenue 14.03M 11.25M 7.04M 4.28M 1.43M
Total other income expense net -1.83M -0.48M -0.50M 0.86M -0.48M
Net income from continuing ops -11.13M -12.91M -12.56M -11.24M -9.83M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 47.66M 25.00M 15.00M 9.39M 10.21M
Total liab 22.22M 23.67M 29.86M 15.32M 7.35M
Total stockholder equity 25.45M 1.33M -14.85M -5.93M 2.85M
Other current liab 0.45M 1.14M 0.53M - 0.64M
Capital stock 133.00M 97.75M 68.65M 65.01M 62.56M
Retained earnings -107.55M -96.42M -83.50M -70.94M -59.70M
Cash 23.02M 2.39M 5.36M 1.74M 4.12M
Total current liabilities 7.68M 14.26M 26.47M 11.52M 2.92M
Net debt - 1.51M 15.18M 6.81M -
Short long term debt 0.15M 3.90M 20.53M 8.55M -
Total current assets 30.50M 7.86M 9.05M 4.32M 5.67M
Net receivables 1.98M 1.12M 0.81M 0.55M 0.39M
Long term debt 2.42M - - - -
Inventory 4.56M 3.65M 2.47M 1.38M 0.93M
Accounts payable 2.63M 3.52M 1.78M 1.07M 0.88M
Non currrent assets other 0.43M 0.37M 0.18M 0.16M 0.18M
Non current assets total 17.16M 17.14M 5.95M 5.07M 4.54M
Capital lease obligations 11.54M 9.91M 1.81M 2.01M 2.66M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -3.03M -1.47M -1.26M -1.64M
Net borrowings 5.25M 2.04M 13.15M 7.30M -0.33M
Total cash from financing activities 30.19M 6.78M 13.56M 8.14M 10.77M
Net income -11.13M -12.91M -12.56M -11.24M -9.83M
Change in cash 20.60M -2.93M 3.56M -2.36M 2.34M
Begin period cash flow 2.39M 5.36M 1.74M 4.12M 1.78M
End period cash flow 23.02M 2.39M 5.36M 1.74M 4.12M
Total cash from operating activities -7.23M -6.68M -8.52M -9.24M -6.79M
Issuance of capital stock 18.26M 4.33M 0.00M 0.00M 7.47M
Depreciation 1.62M 1.25M 0.84M 0.71M 0.39M
Change to inventory -0.90M -1.19M -1.09M -0.45M -0.83M
Change to account receivables -0.86M -0.31M -0.26M -0.16M -0.17M
Capital expenditures 2.35M 2.83M 1.47M 1.26M 1.64M
Change in working capital -1.94M -0.56M 0.76M -0.31M -0.10M
Stock based compensation 0.60M 0.60M 0.56M 1.35M 3.37M
Other non cash items 3.63M 1.02M 0.87M 0.12M -1.26M
Free cash flow -9.58M -9.52M -10.00M -10.50M -8.43M

Peer Comparison*

Sector: Consumer Defensive Industry: Packaged Foods

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
BHST
BioHarvest Sciences Inc. Common Stock
0.01
0.82%
1.23 - 169.49 2.90 4.01 2.70 -10.25
NSRGF
Nestle SA
-1.84
1.77%
102.15 26.86 18.76 3.13 7.10 3.81 21.70
NSRGY
Nestle SA ADR
-0.80
0.78%
102.21 26.82 18.66 3.18 7.07 3.81 21.70
DANOY
Danone PK
-0.17
1.11%
15.18 24.23 17.64 1.88 2.57 1.88 11.70
GPDNF
Danone S.A
-
-%
76.59 20.30 14.75 1.65 2.24 1.76 10.92

Profile*

BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and sale of science-based health and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.

1140-625 Howe Street, Vancouver, BC, Canada, V6C 2T6

604 689 5722

89

Name Title Year Born
Dr. Zaki Rakib Ph.D. Co-Founder, Executive Chairman & President 1959
Mr. Ilan Sobel Chief Executive Officer NA
Dr. Yochi Hagay Ph.D. Co-Founder, CTO & Member of Scientific Advisory Board 1958
Dr. Ilana Belzer Ph.D. Chief Operating Officer 1960
Mr. David K. Ryan VP of Investor Relations & Secretary 1967
Dr. Brian S. Cornblatt Chief Medical Officer & Member of Scientific Advisory Board NA
Ms. Bar Dichter Chief Financial Officer NA
Mr. Matthew Joseph Zrebiec Vice President of Business Development NA
Dr. Yoheved Hagay Ph.D. Co-Founder, CTO & Member of Scientific Advisory Board 1958
Dr. Malkit Azachi Ph.D. Vice President of Research & Development NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…